Join our daily newsletter At The Bell to receive exclusive market insights
- Bluechiip Limited (BCT) announces the registration of its own branded long-term storage tubes with global partners
- The tubes, known as cryovials, have now been linked to the United States FDA and the European CE IVD certification
- The company has now globally launched its Bluechiip-enabled sample management solutions product line
- Bluechiip plans to market and sell its line into North America, Australia and New Zealand as well as global partners across Europe and Asia
- Bluechiip shares are in the green, up 19.6 per cent to trade at 6.7 cents at 12:15 pm AEDT
Bluechiip Limited (BCT) has announced the registration of its own branded long-term storage tubes with global partners.
The tubes, known as cryovials, have now been linked to the United States FDA and the European CE IVD certification.
The tubes are designed to seal tightly and preserve tissue and cells in temperatures as low as -196 degrees.
Bluechiip-enabled sample management solutions have now been worldwide released by the firm.
These include sample storage consumables, readers and stream sample management software.
Bluechiip plans to market and sell its line into North America, Australia and New Zealand as well as global partners across Europe and Asia.
Bluechiip managing director Andrew McLellan says the announcement is an exciting move.
“We are now talking directly to end customers in biobanking, research, clinical trials, and pharmaceutical companies across the life sciences space,” he said.
“Most importantly for our end customers we are focused on redefining quality, driving productivity and at the end of the day providing confidence in every sample and we have already received orders, and made installations, during the past two months in Europe and Australia and look forward to expanding our customer base especially in North America.”
Bluechiip shares are in the green, up 19.6 per cent to trade at 6.7 cents at 12:15 pm AEDT.
